Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,577.63
(
-0.71%
)
US TECH 100
23,635.00
(
-0.68%
)
Dow Jones
45,835.17
(
-0.84%
)
Brent Oil
106.74
(
0.15%
)
Bitcoin
69,441.78
(
-2.53%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 45663

Tuesday, 04/24/2007 8:51:54 PM

Tuesday, April 24, 2007 8:51:54 PM

Post# of 257259
Re: Proposed MS-treatment survey

>can you throw these other drugs in the mix?
Tysabri
Copaxone
Rituxan
Avonex
Betaseron
Rebif
FTY720
<

We can do it this way, but I think Avonex, Rebif, and Betaseron ought to be combined into a single answer choice because they are essentially the same drug.

Also, if the date to be used in the survey is 2010, that’s too soon for FTY720 to have any material impact.

Comments?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now